IRNT presents a gamma squeeze setup with 273% of float claimed by institutional obligations (56% short interest + 217% ITM call options), with price targets ranging from $29-$530 depending on squeeze intensity. Key risks include low float volatility, surprise earnings release, and the highly speculative nature of the play.